ChartRow logo
PHG
$26.00+1.96%
as of close, Oct 20, 2026
☾ AH $26.00 +1.96%
Koninklijke Philips N.V. NY Registry SharesStock · Healthcare
PeersGEHCSTEZBHSNNDXCMGMED
Share this page

PHG financial statements

The full income statement, balance sheet, and cash-flow statement for Koninklijke Philips N.V. NY Registry Shares (PHG), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2017-12 926.2M2018-12 914.2M2019-12 891.0M2020-12 905.1M2021-12 870.2M2022-12 881.5M2023-12 906.4M2024-12 925.0M2025-12 962.9M+4.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue20.2B+3.5%19.5B-0.8%19.6B+4.8%18.8B-7.6%20.3B+2.8%
9.12B+8.4%8.41B+4.4%8.05B+6.4%7.57B-10.7%8.48B-4.9%
Cost of revenue11.1B-0.2%11.1B-4.4%11.6B+3.6%11.2B-5.3%11.8B+9.1%
Research & development1.92B+1.8%1.89B-7.5%2.04B-7.1%2.20B+3.0%2.14B+2.8%
Operating income1.61B+181.6%572M+560.1%-124M+92.3%-1.61B-345.9%654M-54.6%
Interest expense392M-6.5%419M+3.0%407M+49.8%271M+22.1%222M-3.5%
Pre-tax income1.34B+905.3%133M+123.4%-569M+68.8%-1.82B-402.5%602M-56.4%
Income tax319M-69.4%1.04B+1419.5%-78.9M+33.6%-119M+2.4%-122M-150.4%
1.01B+234.4%-755M-50.8%-501M+70.3%-1.69B-143.0%3.93B+188.5%
Net income to common1.01B+233.4%-759M-50.7%-504M+70.2%-1.69B-143.1%3.93B+190.1%
$1.05+229.7%-$0.81-53.1%-$0.53+70.2%-$1.78-142.9%$4.14+181.5%
EPS (basic)$1.06+231.1%-$0.81-53.1%-$0.53+70.2%-$1.78-142.7%$4.16+178.8%
Weighted-avg shares (basic)948M+1.6%933M-1.6%948M-0.4%952M+0.9%944M+4.0%
Weighted-avg shares (diluted)963M+3.1%933M-1.6%948M-0.4%952M—
Dividends per share$0.96+4.6%$0.92+0.0%$0.92+2.8%$0.89-11.1%$1.01+3.7%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
11.7B+12.1%10.4B-5.1%11.0B-0.0%11.0B-6.3%11.7B-15.1%
Cash & equivalents3.28B+31.6%2.50B+20.9%2.06B+64.5%1.25B-51.9%2.61B-34.3%
Accounts receivable4.15B+8.7%3.82B-7.4%4.12B-6.4%4.40B+2.7%4.29B-16.1%
Inventory3.37B+1.5%3.32B-13.8%3.85B-11.0%4.33B+10.9%3.91B+6.1%
31.7B+5.2%30.1B-7.2%32.5B-1.1%32.8B-6.4%35.1B+2.9%
Property, plant & equipment——2.74B-2.9%2.82B-7.7%3.06B-7.3%
Goodwill10.9B+1.0%10.8B-1.0%10.9B-0.5%11.0B-9.1%12.0B+22.2%
Total non-current assets20.0B+1.5%19.7B-8.3%21.5B-1.7%21.9B-6.4%23.3B+15.1%
8.83B+4.3%8.47B-7.5%9.15B+7.8%8.49B+0.6%8.44B-11.3%
Short-term & current debt1.29B+186.2%451M-23.2%587M-34.8%901M+73.3%520M-63.3%
18.8B+6.6%17.6B-8.1%19.1B——
Long-term debt8.15B+10.3%7.39B-4.8%7.77B-0.2%7.78B+6.1%7.33B+4.5%
12.9B+3.2%12.5B-6.0%13.3B-6.3%14.2B-13.3%16.4B+12.0%
Total equity incl. non-controlling12.9B+3.2%12.5B-6.0%13.3B-6.3%14.2B-13.3%16.4B+12.0%
Common shares issued——39.3M+177.5%14.2M+123.4%6.35M-64.9%
Shares outstanding (cover)963M+4.1%925M+2.1%906M+2.8%881M+1.3%870M-3.9%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Depreciation & amortization1.27B-15.3%1.50B+10.3%1.36B-19.1%1.69B+7.7%1.56B-6.1%
Capital expenditure304M-11.2%343M-8.1%373M-20.1%467M-0.5%470M-15.1%
Long-term debt issued1.20B+55.7%768M+30.5%588M-77.8%2.65B+2844.6%89.9M-92.6%
Long-term debt repaid689M-16.5%825M+1.2%815M-47.3%1.55B+333.5%357M+5.1%
Common stock issued
————27.2M-48.1%
Common stock repurchased—64.9M0.00-100.0%25.2M-97.2%895M+504.1%
Dividends paid371M+34211.7%1.08M-50.0%2.16M-99.5%433M-24.0%570M+49902.5%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap26.1B+11.3%23.4B+13.9%20.6B+57.7%13.0B-59.3%32.1B-34.6%
P/E25.7×——3.3×-59.3%8.2×-77.3%
P/S1.3×+7.5%1.2×+9.6%1.1×+70.6%0.6×-59.3%1.6×-36.4%
P/B2.0×+7.8%1.9×+29.4%1.5×+81.8%0.8×-59.3%2.0×-41.6%
Earnings yield3.9%——30.1%+145.8%12.3%+341.1%
Dividend yield3.6%-2.2%3.6%-7.8%3.9%-34.0%6.0%+118.7%2.7%+52.5%
Source filing20-F20-F20-F20-F/A20-F

About this data

Source: PHG’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all PHG filings on SEC EDGAR → Not investment advice.